Clients News • MC Services corporate website
5522
paged,page-template-default,page,page-id-5522,paged-5,page-paged-5,bridge-core-2.1.4,qode-listing-1.0.1,qode-social-login-1.0,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode-title-hidden,paspartu_enabled,qode_grid_1400,footer_responsive_adv,qode-content-sidebar-responsive,qode-child-theme-ver-1.0.0,qode-theme-ver-20.1,qode-theme-bridge,disabled_footer_top,qode_header_in_grid,bridge-child,wpb-js-composer js-comp-ver-6.1,vc_responsive

CLIENT NEWS

 

 

  • Newron Receives Third Tranche from Financing Agreement with European Investment Bank (EIB)
    www.newron.com
  • CENTOGENE AG: Corona-Testergebnisse zukünftig in der Blockchain verankert – CENTOGENE und Ubirch schaffen sichere Lösung für den erfolgreichen Kampf gegen COVID-19
    www.centogene.com
  • CENTOGENE AG: CENTOGENE gibt die Eröffnung eines Labors in Hamburg (Deutschland) bekannt
    www.centogene.com
  • Adocia announces first quarter 2020 financial results and update on the impact of COVID-19
    www.adocia.com
  • Security of supply during the coronavirus crisis: ABF Pharmaceutical Services classified as “critical infrastructure” by the Federal Chancellery
    www.gba-group.com
  • AiCuris gets involved in the fight against Corona
    www.aicuris.com
  • APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19
    www.apeiron-biologics.com
  • France Biotech: A new Patient-Centered Endowment Fund launched by France Biotech: “HealthTech For Care”
    www.france-biotech.fr
  • BIO-Europe Spring® 2020 Stages Largest Fully Digital Life Science Partnering Event with Great Success
    www.ebdgroup.knect365.com
  • InflaRx Doses First Patient in Multicenter Randomized Clinical Trial in Severe Progressed COVID-19 Pneumonia in Europe upon Receipt of Initial Positive Human Data with InflaRx’s anti-C5a Technology
    www.inflarx.de